Accounting for the Public Interest: A Revenue Recognition Dilemma: Question 3 Post a condensed version of your answer to question 3: 3. Operating cash flow is often referred to as the lifeblood of a firm. The vaccine makers received cash up-front from the government for the stockpiled vaccines. Such cash would be reported to stakeholders (financial analysts, stockholders, lenders, etc.) in the operating cash flow section of the Statement of Cash Flows in the fiscal period of receipt. Given this, why would these pharmaceutical companies be so concerned about when the revenue related to this cash is recognized for income statement purposes? In your response, consider how recognized revenues are used by firm stakeholders. Accounting for the Public Interest: A Revenue Recognition Dilemma Question 5 Provide your answer to the following question contained with the Accounting for the Public Interest: A Revenue Recognition Dilemma case: 5. After careful consideration of the public interest consequences of ASC 605-15-599-1, would it be appropriate for the SEC to modify its revenue recognition position exclusively for pharmaceutical companies stockpiling vaccines for the federal government by allowing them to recognize revenue on stockpiled vaccines? Why ar why not